Annual Gross Profit
$12.23 B
+$930.10 M+8.23%
December 31, 2024
Summary
- As of February 20, 2025, REGN annual gross profit is $12.23 billion, with the most recent change of +$930.10 million (+8.23%) on December 31, 2024.
- During the last 3 years, REGN annual gross profit has fallen by -$1.40 billion (-10.29%).
- REGN annual gross profit is now -10.29% below its all-time high of $13.63 billion, reached on December 31, 2021.
Performance
REGN Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$3.22 B
-$5.80 M-0.18%
December 31, 2024
Summary
- As of February 20, 2025, REGN quarterly gross profit is $3.22 billion, with the most recent change of -$5.80 million (-0.18%) on December 31, 2024.
- Over the past year, REGN quarterly gross profit has increased by +$306.50 million (+10.51%).
- REGN quarterly gross profit is now -27.47% below its all-time high of $4.44 billion, reached on June 30, 2021.
Performance
REGN Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$12.23 B
+$306.50 M+2.57%
December 31, 2024
Summary
- As of February 20, 2025, REGN TTM gross profit is $12.23 billion, with the most recent change of +$306.50 million (+2.57%) on December 31, 2024.
- Over the past year, REGN TTM gross profit has increased by +$930.10 million (+8.23%).
- REGN TTM gross profit is now -12.47% below its all-time high of $13.97 billion, reached on March 31, 2022.
Performance
REGN TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
REGN Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.2% | +10.5% | +8.2% |
| 3 y3 years | -10.3% | +10.5% | +8.2% |
| 5 y5 years | +111.2% | +10.5% | +8.2% |
REGN Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -10.3% | +15.3% | -18.8% | +25.9% | -12.5% | +15.3% |
| 5 y | 5-year | -10.3% | +111.2% | -27.5% | +100.1% | -12.5% | +111.2% |
| alltime | all time | -10.3% | >+9999.0% | -27.5% | >+9999.0% | -12.5% | >+9999.0% |
Regeneron Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $12.23 B(+8.2%) | $3.22 B(-0.2%) | $12.23 B(+2.6%) |
| Sep 2024 | - | $3.23 B(+5.3%) | $11.93 B(+2.6%) |
| Jun 2024 | - | $3.07 B(+13.1%) | $11.62 B(+2.8%) |
| Mar 2024 | - | $2.71 B(-7.1%) | $11.31 B(+0.1%) |
| Dec 2023 | $11.30 B(+6.5%) | $2.92 B(-0.3%) | $11.30 B(+0.4%) |
| Sep 2023 | - | $2.93 B(+6.3%) | $11.26 B(+2.8%) |
| Jun 2023 | - | $2.75 B(+1.8%) | $10.95 B(+1.8%) |
| Mar 2023 | - | $2.70 B(-5.9%) | $10.76 B(+1.4%) |
| Dec 2022 | $10.61 B(-22.2%) | $2.87 B(+9.8%) | $10.61 B(-9.4%) |
| Sep 2022 | - | $2.62 B(+2.3%) | $11.71 B(-3.2%) |
| Jun 2022 | - | $2.56 B(-0.0%) | $12.09 B(-13.5%) |
| Mar 2022 | - | $2.56 B(-35.5%) | $13.97 B(+2.5%) |
| Dec 2021 | $13.63 B(+84.8%) | $3.97 B(+32.3%) | $13.63 B(+16.2%) |
| Sep 2021 | - | $3.00 B(-32.5%) | $11.73 B(+9.1%) |
| Jun 2021 | - | $4.44 B(+100.2%) | $10.76 B(+34.7%) |
| Mar 2021 | - | $2.22 B(+7.3%) | $7.99 B(+8.3%) |
| Dec 2020 | $7.38 B(+27.4%) | $2.07 B(+2.5%) | $7.38 B(+6.2%) |
| Sep 2020 | - | $2.02 B(+20.5%) | $6.95 B(+7.8%) |
| Jun 2020 | - | $1.68 B(+4.1%) | $6.45 B(+3.9%) |
| Mar 2020 | - | $1.61 B(-1.9%) | $6.20 B(+7.1%) |
| Dec 2019 | $5.79 B(+22.5%) | $1.64 B(+8.1%) | $5.79 B(+31.3%) |
| Sep 2019 | - | $1.52 B(+6.0%) | $4.41 B(-0.8%) |
| Jun 2019 | - | $1.43 B(+19.3%) | $4.45 B(-1.9%) |
| Mar 2019 | - | $1.20 B(+358.0%) | $4.53 B(-4.1%) |
| Dec 2018 | $4.73 B(-13.6%) | $262.10 M(-83.1%) | $4.73 B(-20.4%) |
| Sep 2018 | - | $1.55 B(+2.4%) | $5.94 B(+2.7%) |
| Jun 2018 | - | $1.52 B(+8.6%) | $5.79 B(+2.6%) |
| Mar 2018 | - | $1.40 B(-5.4%) | $5.64 B(+3.0%) |
| Dec 2017 | $5.48 B(+20.0%) | $1.48 B(+5.7%) | $5.48 B(+6.3%) |
| Sep 2017 | - | $1.40 B(+2.1%) | $5.15 B(+4.5%) |
| Jun 2017 | - | $1.37 B(+10.7%) | $4.93 B(+4.8%) |
| Mar 2017 | - | $1.23 B(+7.2%) | $4.71 B(+3.2%) |
| Dec 2016 | $4.56 B(+22.9%) | $1.15 B(-2.0%) | $4.56 B(+3.8%) |
| Sep 2016 | - | $1.18 B(+2.8%) | $4.40 B(+3.5%) |
| Jun 2016 | - | $1.14 B(+5.0%) | $4.25 B(+5.8%) |
| Mar 2016 | - | $1.09 B(+10.3%) | $4.01 B(+8.2%) |
| Dec 2015 | $3.71 B(+41.9%) | $987.25 M(-4.0%) | $3.71 B(+7.0%) |
| Sep 2015 | - | $1.03 B(+13.0%) | $3.47 B(+11.5%) |
| Jun 2015 | - | $909.78 M(+15.8%) | $3.11 B(+10.3%) |
| Mar 2015 | - | $785.66 M(+5.8%) | $2.82 B(+7.8%) |
| Dec 2014 | $2.61 B(+34.1%) | $742.86 M(+10.8%) | $2.61 B(+7.4%) |
| Sep 2014 | - | $670.20 M(+8.2%) | $2.43 B(+4.8%) |
| Jun 2014 | - | $619.32 M(+6.4%) | $2.32 B(+9.5%) |
| Mar 2014 | - | $582.17 M(+3.5%) | $2.12 B(+8.8%) |
| Dec 2013 | $1.95 B(+50.6%) | $562.30 M(+0.7%) | $1.95 B(+10.0%) |
| Sep 2013 | - | $558.45 M(+33.6%) | $1.77 B(+9.3%) |
| Jun 2013 | - | $418.03 M(+1.8%) | $1.62 B(+9.1%) |
| Mar 2013 | - | $410.61 M(+6.8%) | $1.49 B(+14.8%) |
| Dec 2012 | $1.29 B(+193.0%) | $384.43 M(-5.7%) | $1.29 B(+25.7%) |
| Sep 2012 | - | $407.54 M(+44.2%) | $1.03 B(+42.1%) |
| Jun 2012 | - | $282.56 M(+28.7%) | $724.42 M(+31.9%) |
| Mar 2012 | - | $219.49 M(+82.9%) | $549.28 M(+24.4%) |
| Dec 2011 | $441.61 M(-3.4%) | $119.99 M(+17.2%) | $441.61 M(-2.9%) |
| Sep 2011 | - | $102.38 M(-4.7%) | $454.70 M(-0.7%) |
| Jun 2011 | - | $107.42 M(-3.9%) | $457.92 M(-1.7%) |
| Mar 2011 | - | $111.82 M(-16.0%) | $465.99 M(+2.0%) |
| Dec 2010 | $456.98 M | $133.08 M(+26.0%) | $456.98 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | $105.61 M(-8.6%) | $420.32 M(-2.6%) |
| Jun 2010 | - | $115.48 M(+12.3%) | $431.69 M(+6.4%) |
| Mar 2010 | - | $102.82 M(+6.6%) | $405.81 M(+7.5%) |
| Dec 2009 | $377.58 M(+59.0%) | $96.41 M(-17.6%) | $377.58 M(+12.3%) |
| Sep 2009 | - | $116.98 M(+30.6%) | $336.38 M(+18.2%) |
| Jun 2009 | - | $89.60 M(+20.1%) | $284.68 M(+11.3%) |
| Mar 2009 | - | $74.59 M(+35.1%) | $255.74 M(+7.7%) |
| Dec 2008 | $237.53 M(+90.0%) | $55.21 M(-15.4%) | $237.53 M(+30.3%) |
| Sep 2008 | - | $65.29 M(+7.6%) | $182.33 M(+55.8%) |
| Jun 2008 | - | $60.65 M(+7.6%) | $117.04 M(+107.6%) |
| Mar 2008 | - | $56.38 M(+468.6%) | $56.38 M(+2.0%) |
| Dec 2007 | $125.02 M(+126.1%) | - | - |
| Dec 2006 | $55.30 M(-2.4%) | $9.92 M(-21.1%) | $55.30 M(-8.8%) |
| Sep 2006 | - | $12.57 M(-23.6%) | $60.66 M(-0.6%) |
| Jun 2006 | - | $16.45 M(+0.5%) | $61.04 M(+3.0%) |
| Mar 2006 | - | $16.37 M(+7.1%) | $59.28 M(+4.7%) |
| Dec 2005 | $56.64 M(-64.3%) | $15.28 M(+18.0%) | $56.64 M(-33.3%) |
| Sep 2005 | - | $12.95 M(-11.9%) | $84.97 M(-14.6%) |
| Jun 2005 | - | $14.69 M(+7.1%) | $99.56 M(-11.7%) |
| Mar 2005 | - | $13.72 M(-68.5%) | $112.76 M(-29.0%) |
| Dec 2004 | $158.80 M(+212.5%) | $43.62 M(+58.4%) | $158.80 M(+17.2%) |
| Sep 2004 | - | $27.53 M(-1.3%) | $135.55 M(+12.4%) |
| Jun 2004 | - | $27.89 M(-53.3%) | $120.57 M(+19.0%) |
| Mar 2004 | - | $59.77 M(+193.5%) | $101.33 M(+98.6%) |
| Dec 2003 | $50.82 M(+227.8%) | $20.36 M(+62.3%) | $51.03 M(+50.7%) |
| Sep 2003 | - | $12.55 M(+45.1%) | $33.85 M(+29.0%) |
| Jun 2003 | - | $8.65 M(-8.7%) | $26.23 M(+23.2%) |
| Mar 2003 | - | $9.47 M(+197.2%) | $21.29 M(+37.3%) |
| Dec 2002 | $15.51 M(+0.3%) | $3.19 M(-35.4%) | $15.51 M(-0.3%) |
| Sep 2002 | - | $4.93 M(+32.9%) | $15.56 M(+4.9%) |
| Jun 2002 | - | $3.71 M(+0.7%) | $14.84 M(-1.2%) |
| Mar 2002 | - | $3.68 M(+13.7%) | $15.02 M(-2.9%) |
| Dec 2001 | $15.46 M(-64.6%) | $3.24 M(-23.0%) | $15.46 M(-31.6%) |
| Sep 2001 | - | $4.21 M(+8.0%) | $22.62 M(-26.8%) |
| Jun 2001 | - | $3.89 M(-5.6%) | $30.91 M(-23.3%) |
| Mar 2001 | - | $4.13 M(-60.3%) | $40.30 M(-7.6%) |
| Dec 2000 | $43.71 M(+41.5%) | $10.40 M(-16.7%) | $43.62 M(-3.1%) |
| Sep 2000 | - | $12.49 M(-6.0%) | $45.02 M(+5.1%) |
| Jun 2000 | - | $13.28 M(+78.4%) | $42.83 M(+25.1%) |
| Mar 2000 | - | $7.45 M(-36.9%) | $34.25 M(+10.8%) |
| Dec 1999 | $30.90 M(-7.2%) | $11.80 M(+14.6%) | $30.90 M(+23.1%) |
| Sep 1999 | - | $10.30 M(+119.1%) | $25.10 M(+3.3%) |
| Jun 1999 | - | $4.70 M(+14.6%) | $24.30 M(-23.8%) |
| Mar 1999 | - | $4.10 M(-31.7%) | $31.90 M(-4.5%) |
| Dec 1998 | $33.30 M(+37.0%) | $6.00 M(-36.8%) | $33.40 M(+5.4%) |
| Sep 1998 | - | $9.50 M(-22.8%) | $31.70 M(+4.6%) |
| Jun 1998 | - | $12.30 M(+119.6%) | $30.30 M(+25.7%) |
| Mar 1998 | - | $5.60 M(+30.2%) | $24.10 M(-0.4%) |
| Dec 1997 | $24.30 M(+5.7%) | $4.30 M(-46.9%) | $24.20 M(+21.6%) |
| Sep 1997 | - | $8.10 M(+32.8%) | $19.90 M(+68.6%) |
| Jun 1997 | - | $6.10 M(+7.0%) | $11.80 M(+107.0%) |
| Mar 1997 | - | $5.70 M(-181.4%) | $5.70 M(-181.4%) |
| Dec 1996 | $23.00 M(-518.2%) | - | - |
| Sep 1993 | - | -$7.00 M(+133.3%) | -$7.00 M(+48.9%) |
| Dec 1991 | -$5.50 M(+323.1%) | -$3.00 M(+500.0%) | -$4.70 M(+176.5%) |
| Sep 1991 | - | -$500.00 K(-58.3%) | -$1.70 M(+41.7%) |
| Jun 1991 | - | -$1.20 M | -$1.20 M |
| Dec 1990 | -$1.30 M | - | - |
FAQ
- What is Regeneron Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual gross profit year-on-year change?
- What is Regeneron Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly gross profit year-on-year change?
- What is Regeneron Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals TTM gross profit year-on-year change?
What is Regeneron Pharmaceuticals annual gross profit?
The current annual gross profit of REGN is $12.23 B
What is the all time high annual gross profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual gross profit is $13.63 B
What is Regeneron Pharmaceuticals annual gross profit year-on-year change?
Over the past year, REGN annual gross profit has changed by +$930.10 M (+8.23%)
What is Regeneron Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of REGN is $3.22 B
What is the all time high quarterly gross profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly gross profit is $4.44 B
What is Regeneron Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, REGN quarterly gross profit has changed by +$306.50 M (+10.51%)
What is Regeneron Pharmaceuticals TTM gross profit?
The current TTM gross profit of REGN is $12.23 B
What is the all time high TTM gross profit for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high TTM gross profit is $13.97 B
What is Regeneron Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, REGN TTM gross profit has changed by +$930.10 M (+8.23%)